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inflammation between childhood and adult-onset asthma. A total of 47 asthmatic
subjects were recruited from patients attending outpatient clinic. A group of 32
adults, mean age 42.8 years (yrs) and a group of 15 children, mean age 11.7 yrs were
included. The two groups did not differ in respect to gender, dose of inhaled
corticosteroids, atopy status or duration of asthma (mean duration 7.75 yr). Lung
function tests, and sputum induction were performed. Flowcytometry was used to
study cell population and interleukin-8, eosinophilic cationic protein (ECP) and
granulocyte-macrophage colony stimulating factor were measured by enzyme-linked
immunosorbent assay (ELISA).
Three out of 15 (20%) of the children and 6 out of 32 (19%) of the adult patients
were unable to produce a sufficient sputum sample. However, all individuals
tolerated the procedure well. The viability of induced sputum cells did not differ
among adult-onset asthmatics and children with asthma. Children had greater
number of total cells in induced sputum compared with adult subjects (P ¼ 0:02). No
statistical difference in T-lymphocytes subsets was found between the two groups,
except for CD25 (P ¼ 0:04). A negative correlation was found between forced
expiratory volume (FEV1) values and ECP levels (r ¼ 0:338, P ¼ 0:04) in the whole
population (children and adults).Elsevier Ltd. All rights reserved.
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Comparison of induced sputum inflammatory profiles between childhood and adult-onset asthma 1443Our study showed that the immunopathology of pediatric and adult asthma is
similar and sputum induction provides opportunities for comparison of airway
inflammation in childhood and adult asthma safely.
& 2005 Elsevier Ltd. All rights reserved.Introduction
Asthma is a global health-care concern affecting
almost 8% of the adult population and possibly up to
29% of children.1 Although both childhood and
adulthood asthma share similar features, there are
epidemiological and clinical characteristics sug-
gesting a difference in the nature and magnitude of
airway inflammation.2,3 More than 50% of children
with asthma will suffer from asthma in adult life.1
Although many studies have focused on the
persistence of childhood asthma and its outcome
in transition from childhood to adulthood, the
course of the disease in a given individual is still
unpredictable.2 An adult-onset asthma seems to be
different compared to childhood-onset asthma
relapsing in adult life concerning the gender, the
severity of asthma symptoms, the functional
impairment, the frequency and the characteristics
of atopy.4 The asthmatic inflammatory response in
adults seems to be orchestrated by CD4+ type 2
lymphocytes (Th2), while other cell types, includ-
ing mast cells and eosinophils may play an
important role.5 On the other hand three childhood
wheezing phenotypes are currently defined; tran-
sient infant wheezing; non-atopic wheezing of the
toddler; and IgE-mediated wheezing asthma.6
Recently, a fourth phenotype, late-onset childhood
asthma has been added to this list.7 The investiga-
tion and characterization of airway inflammation in
childhood asthma might indicate whether the
immunopathogenic pathways begin and childhood
asthmatic continues into adulthood or adult-onset
and childhood-onset asthma are two different
entities.3
The purpose of this report was to describe the
differences of inflammatory indices in the airway
secretions of children with childhood and adults
with adult-onset asthma with similar duration of
the disease. Invasive methods as bronchoalveolar
lavage (BAL) and bronchial biopsies, used in adults
cannot ethically be used in children for this purpose
alone.8 We used the sputum induction procedure;
we counted the sputum inflammatory cell popula-
tions and T-cell subpopulations (CD4+, CD8+ cells)
and analyzed the supernatant fraction for soluble
granulocyte chemotactic factors and release pro-
teins: interleukin-8 (IL-8), granulocyte-macrophage
colony stimulating factor (GM-CSF), and eosinophi-lic cationic protein (ECP). Considering the rela-
tively limited information regarding the application
of sputum induction in children, a second objective
of our study was to assess the safety and efficacy of
this procedure in children asthmatics.Methods
Subjects
A total of 47 subjects were recruited from patients
attending outpatient clinics of the University
Hospital of Crete. Asthma was diagnosed by a
history of recurrent wheezing and chest tightness
and a previous physician diagnosis, according to the
National Heart, Lung, and Blood Institute (NHLBI)
criteria 2000 and asthma severity was documented
by: (a) previous medical records involving asthma
history, (b) symptom diary card and, (c) spirome-
try.1 The study population included a group of 32
adult asthmatics with adult-onset disease (group 1,
mean age 42.8 yrs), and a group of 15 asthmatic
children (group 2, mean age 11.7 yrs). The onset of
the disease in the adult group was defined and was
always after the age of 15 yrs old, as it was
confirmed from their medical records (no wheez-
ing, no hospitalization due to bronchitis, no use of
bronchodilators or inhaled/systemic steroids be-
fore the age of 15 yrs). Subjects were matched on
duration of disease. All subjects were lifelong non-
smokers, requiring inhaled steroids (200–800mcg
budesonide or 100–400mcg fluticasone daily) and
short acting inhaled b2 agonists as needed. No
patient was treated with long acting b2-agonists,
anticholinergics, theophylline or was receiving oral
corticosteroids or long-term oxygen therapy
(LTOT). Exclusion criteria were co-existing pulmon-
ary or systemic disease, pregnancy, mental dis-
ability and use of other drugs than inhaled steroids
and b2-agonists. Medication was stable for at least
1 month prior the study, except for the use of short
acting inhaled b2-agonists. No subjects had a
history of upper respiratory tract infection within
previous 6 weeks. All subjects were informed and
gave their consent prior to the beginning of the
study. The study was approved by the Ethics
Committee of the University Hospital of Crete.
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Each subject completed a 2-day protocol. A
detailed medical history was taken on the first
visit, followed by the lung function and skin prick
tests. On the second visit (no more than a week
from the first visit) blood was taken and sputum
induction was performed. Peripheral blood samples
were used for specific radioallergosorbent tests
(RAST), IgE and eosinophil counts. Atopic status was
defined as having positive skin prick test to at least
one of most common aeroallergen, or a positive
specific RAST.
Lung function tests
Spirometry with bronchodilation test was per-
formed with a computerized system (MasterLab;
2.12, Jaeger, Wuerzburg, Germany) according to
standardized guidelines.9 Subjects did not use short
or long acting bronchodilators 12 h prior to the
measurements and did not drink tea or coffee in
the morning of the spirometry and induced sputum
session. Spirometry followed by sputum induction
always took place between 8.00 and 11.00 a.m.
Sputum induction
Sputum was induced as previously described.10
Briefly before the hypertonic saline challenge was
commenced, pre-treatment with 200mcg salbuta-
mol was given and the sputum induction procedure
was carefully explained to the subject. The
investigator demonstrated how to cough and clear
the throat in order to sample properly the mucus
from the airways into the mouth and then to empty
into a sterile container. Subjects were asked to
blow their nose and to rinse their mouth with water
before the procedure to eliminate squamous cell
contamination. They were also asked to cough
between each dose of nebulized saline (3%, 4%, 5%)
to clear their throat and expectorate into the
container. The procedure continued until an ade-
quate sample was obtained and it was terminated
after three periods of 7min, or earlier if forced
expiratory volume (FEV1) had fallen more than 20%
from its post-bronchodilator baseline value or if
troublesome symptoms occurred.
Sputum processing
Sputum was processed within 15min after termina-
tion of the induction procedure. The viscid portions
of the expectorated sample were separated from
the whole sputum as previously described.10 Theweight of plugs was measured and dithiothreitol
(DTT, Sputolysine; Calbiochem Corp, San Diego, CA,
USA) was freshly prepared in a dilution of 1:10 with
distilled water according to the manufacturer’s
instructions. The volume added was twice the
weight of the plugs. The samples were vortexed
for 30 s in a cell culture polypropylene 50ml tube
and placed in a shaking water bath for 15min at
37 1C to ensure complete homogenization. The
sputum was further diluted with Dulbecco’s phos-
phate buffered saline (D-PBS) in a volume equal to
the sputum plus DTT. The samples were then
filtered through a 48 mm nylon gauze (Thompson,
Ontario, Canada) to remove the residual mucous
contamination. A total cell count was performed
and viability was checked using trypan blue exclu-
sion. The sample was then agitated on a vortex
mixer (initial suspension). Consequently, the sus-
pension was centrifuged at 400g for 5min and the
pellet was resuspended with 500 ml RPMI-1640+10%
fetal calf serum (FCS). The supernatant was
aspirated and stored in Eppendorf cups at 80 1C
for further analysis.
The cell suspension was then adjusted to achieve
a concentration of 0.75 106 cells/ml. Cytospins on
super frost plus slides were made using 50 ml of the
cell suspension and centrifuging at 300 rpm with
low deceleration over 5min (Aero-spray, Wescor,
Utah, USA). Two slides were stained for differential
cell counts with May Grunwald Giemsa. Differential
cell counts were performed by counting 500
nucleated non-squamous cells in each cytospin in
a blinded fashion by two observers. The mean of
the scores was used for analysis. Countable
cytospins were defined by low salivary contamina-
tion (o20% squamous epithelial cells) and cell
viability 475%. Additionally, 300 ml of sputum
suspension were immediately processed for flow
cytometric analysis.Flowcytometry
The samples prepared as described above, were
analyzed on an Epics Elite (Coultronics, Louton,
United Kingdom) fluorescence activated flow-cyt-
ometer as previously described.11 Briefly, the
lymphocytes were tightly gated by volume and
complexity on a forward, and side light scattering
mode and by CD45+ expression (pan leukocyte
marker). At least 105 cells were analyzed in each
case. The appropriate control was used for sub-
traction of the background. The percentage of one-
and two-, and three-color positive cells were
measured. The following mouse anti-human mono-
clonal antibodies were used for labeling sputum
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France): Phycocyanate (Pcy-5)-conjugated anti-
CD45+, phycoerythrin (PE)-conjugated anti-CD3+,
fluorescein isothiocyanate (FITC)-conjugated anti-
CD4+, PE-conjugated anti- CD25+ and FITC-conju-
gated anti-CD8+. Mouse anti-mouse isotype
matched FITC-, PE-, or Pcy-5-conjugated immuno-
globulins were used as control antibodies.
Fluid phase measurements
The commercial enzyme-linked immunosorbent
assay (ELISA) was used to measure IL-8 and GM-
CSF (Immunotech. Marseille, France). For IL-8 the
sensitivity of the assay was 8 pg/gr, with intra-
assay-CV of 2–5% and inter-assay-CV of 7–10%. For
GM-CSF the sensitivity of the assay was 5 pg/gr,
with intra-CV of 3% and inter-assay-CV of 4–13%.
ECP was measured using the IniCap Fluoroenzy-
meimmunoassay (Art No. 10-9261-01, Pharmacia,
Uppsala, Sweden), with sensitivity of 0.5 mg/gr,
intra-assay-CV of 2–3% and inter-assay-CV of 4–5%.
ECP dilution was made with 0.2% CTAB. All
measurements were performed twice for the same
sample and results were averaged. The mean intra-
sample-CV was always o4%. All essays were
validated according to European Respiratory So-
ciety guidelines.12 Spiking recovery of ECP, IL-8 and
GM-CSF were assessed by adding a known quantity
of purified mediator to different aliquots of sputum
samples. Considering that recovery might differ
between individuals due to differences in factors in
sputum which interfere with detection, sputum
from a range of subjects with childhood (n ¼ 5) and
adult asthma (n ¼ 5) was used. The expected
concentration of the spiked mediator, assuming
100% recovery, was in the mid-part of the standardTable 1 Demographic and clinical characteristics of chil
Ch
n
Sex (M/F) 9/
Age (x7SD) 10
Onset of the disease (yrs of age) 77
Duration (x7SD), yrs 7.
FEV1 (% pred) (x7SD) 97
DFEV1 (% of prebronchodilation) (x7SD) 97
Atopy (%) 91
Treatment (% using)
a2 agonists (short acting) 10
ICS 10
Po0:05.
yP not significant.curve. The spiking recovery of each mediator was
calculated as percentage of the expected value,
which was the sum of the spiked purified mediator
and mediator concentration in the original sputum
sample. Spiking experiments showed good recovery
(mean 480%) for all mediators.
Statistical analysis
Data are presented as mean7SD for normally and as
median (range) for non-normally distributed vari-
ables. Normality was tested by the Shapiro–Wilk
test. Differences between the two groups were
tested using Mann–Whitney test for non-normally,
and the t-test for normally distributed variables.
Correlations were made using the Spearman’s-r
correlation coefficient for non-normally and the
Pearson correlation coefficient for normally dis-
tributed variables. The statistical software Stats-
Direct 2,2,12 (Camcode Cambridge, UK, 2003) was
used for the entire analysis. A P-value ofo0.05 was
considered statistically significant.Results
Three out of 15 (20%) children and 6 out of 32 (19%)
adults were unable to produce a sufficient sputum
sample (defined in terms of cellular composition
containingo20% squamous epithelial cells). Demo-
graphic and clinical characteristics of the patients
are shown in Table 1. The adult-onset asthma group
had lower FEV1 values than the childhood-onset
asthma group, but this difference was not statisti-
cally significant. The two groups did not differ in
respect to gender, steroid treatment, atopy status
or duration of disease (duration (7SD) in childrendren and adult asthmatics.
ildren Adults
¼ 12 n ¼ 26
3 9/17
72.9 40.872.9
4 33716
673.6 7.975.9y
717 90719y
7 11710y
85y
0 100y
0 100y
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tum induction was tolerated well by all subjects,
without any adverse event.Cells in induced sputum
Viability of induced sputum cells did not differ
among adult and children with asthma. The
percentage of squamous epithelial cells on differ-
ential counting was 978% in children and 876.5%
in adults. Total and differential cell counts in
induced sputum are shown in Fig. 1. A tendency
of higher percentages of neutrophils in adults
compared to the children was observed, but the
difference did not reach statistical significance
(44715 vs. 36710, P ¼ 0:10). There was no
statistically significant difference in the percen-
tages of macrophages, eosinophils and lymphocytes
between the two groups. Children had statisti-
cally significant greater number of total cells
( 105 cells/g sputum) (7SD), compared to the
adults asthmatics 161743 vs. 77710, P ¼ 0:002.
The same was true for total numbers of neutrophils
( 105 cells/g sputum) (7SD) (60755 vs. 33723,
P ¼ 0:05), macrophages (88793 vs. 38729, P ¼
0:001), lymphocytes (678 vs. 272, P ¼ 0:006), and
eosinophils (0.0770.06 vs. 0.0370.03, P ¼ 0:006)
(Fig. 1).Flow cytometry
T-lymphocyte subsets CD4+, CD8+ and CD25+ cells
are shown in Fig. 2. No significant difference in
CD4+ and CD8+ cells was found between children
and adults (Fig. 2). Similarly no statistically0
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Figure 1 Differential cell count in children asignificant difference in CD4/CD8 ratio (x7SD) was
found between children and adults (4.573.1 vs.
3.772.2, P ¼ 0:2). The percentages of CD25+ cells
(% of CD3) in children was significantly higher than
in adult asthmatics, P ¼ 0:04 (Fig. 2).
Soluble mediators
The levels of the IL-8, GMCSF and ECP in sputum
supernatant are shown in Fig. 3. No statistically
significant difference was found between the two
groups.
Correlations
A weak but significant correlation between sputum
ECP levels and FEV1 (% of pred.) (r ¼ 0:338,
P ¼ 0:04) was found in the total population
(children and adults). However, the correlation
was not significant when relationship was examined
in each group separately. Only in children, a
statistically significant correlation was found be-
tween ECP levels and CD4+/CD8+ ratio (0.631,
P ¼ 0:03). In adults, a statistically significant
correlation was found between duration of the
disease and FEV1 (% pred.) (r ¼ 0:452, P ¼ 0:02).Discussion
The main findings of this study were that sputum
inflammatory cell counts, T-lymphocyte subpopula-
tions and inflammatory cytokines did not differ
between adults with adult-onset asthma and
children with asthma. This suggests that the airway0
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nd adult asthmatics by induced sputum.
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Figure 2 T-lymphocytes subsets: (A) CD4+, CD8+, and (B) CD25+, in childhood and adult asthma.
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Figure 3 The levels of IL-8, GM-CSF and ECP in sputum supernatant in children and adult asthmatics.
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hood asthma or adult-onset asthma are similar and
that the immunopathogenic pathways might begin
and continue from childhood into adulthood. This
finding supports the use of similar therapeutic
approaches in both groups. In order to further
verify the common pathogenetic mechanisms a
study comparing cell subpopulations and inflamma-
tory indices in adults with childhood-onset and
those with adult-onset asthma should be under-
taken.
Bronchial inflammation in adult asthmatics is
now considered to be the result of a Th2 cytokine
response derived predominantly from activated
CD4+ T cells.13 Although asthma is one of the most
common diseases in childhood, its pathogenesis has
not been studied extensively. Invasive procedures
necessary to obtain lung samples cannot be
performed in children for research purposes alone.
In a study of bronchial biopsies from children with
difficult asthma, there was no statistically signifi-
cant difference in the density of CD4+, interleukin(IL)-4 or IL-5 mRNA+ cells between asthmatic
children and controls.14 In the asthmatic group,
however, there were significant negative correla-
tions between CD4+ T lymphocytes and FEV1 and
FEV1/FVC. In a study of peripheral blood, absolute
numbers of CD4+ and CD8+ T cells did not differ in
the child asthmatics and the controls, but elevated
percentages of both CD4+ and CD8+ cells expressed
activation markers in child asthmatics.15 This is the
first attempt to study T-lymphocyte subsets by flow
cytometry in induced sputum from asthmatic
children. Although sputum lymphocytes represent
only up to 2% of the leucocytes in sputum, flow
cytometry studies have shown that there is an
excess of CD4+ T cells in adults with asthma.11,16,17
Studies using flow cytometry to measure T-lympho-
cytes subpopulations in asthmatic children are
limited.18,19 The present study extended the find-
ing of a predominance of CD4+ over CD8+ T
lymphocytes in children with asthma. The positive
correlation found in this age group between CD4/
CD8 ratio and ECP levels (an eosinophilic marker)
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flammation mediated by CD4+ cells in childhood
asthma.
The only difference in the cell subpopulations
found between the two groups was in CD25+ cells,
where children demonstrated significantly greater
percentages (Fig. 2). T regulatory cells (CD25+) are
a subset of CD4+ lymphocytes, approximately
5–10% in normal individuals, which constitutively
express the IL-2 receptor a-chain.20,21 CD4+CD25+ T
cells likely play an important role in regulating
autoreactive T cells and appear to control the
development of autoimmune disease.20,21 Although
CD4+CD25+ cells have been reported to be in-
creased in peripheral blood from asthmatic pa-
tients, Shi et al. showed that the numbers of
circulating CD4+CD25+ Tcells in normal controls did
not differ from those in atopic non-asthmatics or
asthmatic patients.22–24 They noticed, however, an
increase of CD4+CD25+ cells in the asthmatics
during acute exacerbation, but not in stable
asthmatics.24 The authors conclude that even
though the function of CD4+CD25+ cells is normal
in atopic asthmatics, their suppressive effect is not
sufficient to prevent the development of asthma,
but might be able to affect asthmatic severity
during acute exacerbations.20 Several studies have
also shown that steroids have the capacity to
promote the function of these T cells and this
may contribute to their anti-inflammatory and
immunosuppressive efficacy.20 On the contrary, in
a study of peripheral blood T cells in asthmatic
children, elevated percentages of T cells expressed
CD25 in both atopic and non-atopic child asth-
matics compared with controls.15 Moreover, the
percentages of these cells were significantly re-
duced after inhaled glucocorticoid therapy of the
asthmatics.15 The highest number of CD25+ cells
associated with persistent airway T-lymphocyte
activation according to the study of Redington
et al., but this was not necessarily accompanied by
the recruitment and activation of other inflamma-
tory cells within the airways.25 The conflicting
evidence of the above studies indicate that the role
of CD25+ remains unclear and further investigation
is necessary to elucidate their role in asthma. In the
present study, the number of CD25+ cells in
children was significantly higher than in adult
asthmatics. A safe explanation of this finding
cannot be provided, since the only difference
between the two groups in our study is age and
thus maybe duration of allergen exposure.
The dominant cell in sputum from normal
children is the macrophage and the upper normal
limit for sputum eosinophils in children is 2.5%.2,3
We found that the total cell counts in children wereincreased compared with that in adults. However,
our results on total cell counts are similar with
those of other studies.26–28 In the present study
both groups exhibited increased sputum eosino-
phils, adults (5%) and children (6.5%), without a
statistically significant difference between them.
The relationship between asthma treatment and
sputum eosinophils has been assessed in several
studies, which found that sputum eosinophils were
lower in children taking inhaled-steroids than in
non-users.29,30 Although in the present study both
groups were treated with sufficient doses of inhaled
corticosteroids according to the international
guidelines both groups still exhibited increased
percentage of eosinophils.
In asthma serum and sputum ECP levels are
related to the inflammatory activity of the disease
and may be used to objectively adjust and monitor
anti-inflammatory treatment in children and adults
with asthma.29 In this study, we did not find a
significant difference in sputum eosinophils and
ECP levels between asthmatic children and adults.
This is confirmed by other studies performed in
children, where the results were similar to those
reported in adults.6,31,32 Moreover, no difference
was found in GM-CSF and IL-8 levels and percentage
of sputum neutrophils between the two groups,
that included only mild asthmatics. In adults
neutrophilic inflammation occurs in the more
severe forms of asthma, whereas if this is the case
in children with severe asthma must be investi-
gated.
A significant inverse correlation was found
between the FEV1 and sputum ECP levels in the
study population. Several studies in adult asth-
matics have also shown that higher levels of sputum
ECP are associated with greater airflow obstruction
(reflected in the FEV1).
29,31,32 However, when the
relationship was examined in each group sepa-
rately, the correlation was not statistically signifi-
cant, possibly due to the smaller number of
patients. Additionally, the correlation between
spirometric indices and inflammatory markers in
childhood asthma are still controversial. In accor-
dance with our study, Piacentini et al.30 and Wilson
et al.33 who studied children with mild to moderate
asthma, did not find any correlation. In contrast,
several reports in adults and only one in adoles-
cents with severe asthma have found a correlation
between lung function and inflammatory in-
dices.31,34 One possible explanation is that airway
remodeling is related to chronic airway inflamma-
tion and occurs only after a prolonged period of
time. In our study the vast majority of children
had mild disease and more than 94% of them
had an FEV1 481 (% pred.), which is within
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of values of FEV1 in order to find a significant
correlation.29,34
A recent study by Zieger et al.35 argued that the
duration of asthma was significantly associated
with impaired lung function in children. In our
group of children we did not find this result. One
explanation could be the small number of the
patients. However, in the group of the adult
asthmatics an inverse correlation between the
duration of the disease and FEV1 was found. In
contrast Jenkins et al.3 found that children and
adults whose onset of asthma occurred in childhood
was related to disease duration, but not in patients
with onset of asthma in adulthood.
A secondary end-point of this study was to assess
safety and tolerability of inducing sputum in
asthmatic children. Previous studies have reported
success rates 76–100% of sputum induction in
children, including asthmatic children.9,26 In the
present study 100% of the children subjects
tolerated well the procedure and an adequate
sample was obtained in 82% of adult patients and in
80% of children of age ranging from 6 to 15 yrs. This
is convincing data that sputum induction is an easily
applicable, non-invasive and safe method to study
airway inflammation in children more than 6 yrs
old.
In conclusion, induced sputum cells, and soluble
cytokines studied in children patients with mild
asthma did not differ significantly from those of
adults with the same severity of disease. Whether
measurement of inflammatory markers might con-
tribute to the clinical management of childhood
asthma remains to be evaluated in larger studies.
Moreover, the present study confirmed that sputum
induction is a useful method to study airway
inflammation in childhood and adulthood asthma,
safely and successfully.
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